← Back to Search

Subcutaneous Catheter for IVF Stimulation in Female Infertility

N/A

Recruiting

Led By Richard J Paulson, MD

Research Sponsored by University of Southern California

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately following ovarian stimulation and oocyte retrieval

Awards & highlights

Study Summary

This trial is testing whether a subcutaneous catheter is a feasible option for controlled ovarian stimulation in IVF, as it would be less physically and emotionally burdensome for patients and their partners than daily or twice daily injections.

Who is the study for?

This trial is for women aged 18 to 45 who are undergoing controlled ovarian stimulation as part of in-vitro fertilization (IVF) treatment. There are no specific exclusion criteria mentioned, so it appears open to all women within this age range and treatment category.Check my eligibility

What is being tested?

The study is testing the use of the Neria™ Guard Subcutaneous Catheter during IVF treatments. The goal is to see if using this catheter can make taking medications easier and less stressful compared to daily injections typically used in these procedures.See study design

What are the potential side effects?

While specific side effects aren't listed, subcutaneous catheters may cause local skin reactions, discomfort at the insertion site, or infections. However, since this is a feasibility study, part of its purpose will be to document any potential side effects.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during ovarian stimulation (usually 9-12 days)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during ovarian stimulation (usually 9-12 days)

This trial's timeline: 3 weeks for screening, Varies for treatment, and during ovarian stimulation (usually 9-12 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Device feasibility

Secondary outcome measures

Adverse effects related to the subcutaneous catheter

Clinical pregnancy

Embryo blastulation

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: IVF with Neria™ Guard deviceExperimental Treatment1 Intervention

Patients undergoing IVF with the use of the Neria™ Guard subcutaneous catheter

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor

906 Previous Clinical Trials

1,596,188 Total Patients Enrolled

ConvaTec Inc.Industry Sponsor

44 Previous Clinical Trials

4,760 Total Patients Enrolled

Richard J Paulson, MDPrincipal InvestigatorUniversity of Southern California

Media Library

IVF with the Neria Guard Subcutaneous Catheter Clinical Trial Eligibility Overview. Trial Name: NCT05505474 — N/A

Female Infertility Research Study Groups: IVF with Neria™ Guard device

Female Infertility Clinical Trial 2023: IVF with the Neria Guard Subcutaneous Catheter Highlights & Side Effects. Trial Name: NCT05505474 — N/A

IVF with the Neria Guard Subcutaneous Catheter 2023 Treatment Timeline for Medical Study. Trial Name: NCT05505474 — N/A

Female Infertility Patient Testimony for trial: Trial Name: NCT05505474 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is age a factor for qualification in this clinical examination?

"The age range of participation in this medical trial is 18-45 years old. However, there are 14 research initiatives targeting those below the legal adult age and 33 studies focusing on individuals over 65."

Answered by AI

Are there any vacancies remaining in this medical experiment?

"Clinicaltrials.gov reveals that this healthcare study, which was published on December 1st 2022 and revised recently on August 16th of the same year, is not currently accepting patients. However there are 246 other trials actively enrolling volunteers at the moment."

Answered by AI

Is there any opportunity to join the research protocol?

"A total of 10 women aged 18 to 45 that have fertility difficulties need to be enrolled in this trial. In addition, all applicants must currently go through controlled ovarian stimulation as part of their treatment."

Answered by AI